[Treatment of progressive muscular dystrophy with anabolics and uridine-5-triphosphoric acid].
D000293:Adolescent; D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008696:Methandrostenolone / Q000627:therapeutic use*; D009136:Muscular Dystrophies / Q000188:drug therapy*; D013197:Stanozolol / Q000627:therapeutic use*; D014500:Uracil Nucleotides / Q000627:therapeutic use*
D045930:Anabolic Agents; D014500:Uracil Nucleotides; D013197:Stanozolol; D008696:Methandrostenolone
Tratamiento de la distrofia muscular progresiva con anabólicos y ácido uridín-5-trifosfórico.